Evidence map›Paper›PMID 30271396›Full record

ArticleFrontiers in microbiology2018

Lu Liu, Yu Feng, Yiyi Hu, Mei Kang, Yi Xie, Zhiyong Zong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Novel Insights intoMicrobiology spectrum · 2022
    Article
  6. Simultaneous gut colonization by Klebsiella grimontii and Escherichia coli co-possessing the blaEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  7. Article
  8. Article
  9. Genome-Based Analysis ofPathogens (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Targeting the Sugary Armor ofFrontiers in cellular and infection microbiology · 2019
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lu LiuCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Yu FengCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Yiyi HuCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Mei KangLaboratory of Clinical Microbiology, Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Yi XieLaboratory of Clinical Microbiology, Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Zhiyong ZongCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Sichuan University · CNWest China Hospital of Sichuan University · CNState Key Laboratory of Biotherapy

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

carbapenemaseKlebsiellaKlebsiella grimontiiKlebsiella oxytocaKPC-2

Identifiers

PMID30271396
PMCPMC6142883
OpenAlexW2889770383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.